Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice

por Zobel, Michael John, Zamora, Abigail K, Wu, Hong-wei, Sun, Jianping, Lascano, Danny, Malvar, Jemily, Wang, Larry, Sheard, Michael A, Seeger, Robert C, Kim, Eugene S
Publicado 2020